Previous 10 | Next 10 |
Nasdaq has determined that the securities of the biotechnology company AnPac Bio-Medical Science ( NASDAQ: ANPC ) will delist over non compliance with the minimum $2.5M stockholders' equity requirement. The company now needs to timely request for a hearing before the Nasdaq Heari...
New York, NY, Jan. 20, 2023 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (the “Company”) (Nasdaq: ANPC ), a biotechnology company with operations in the United States and China focused on early cancer screening and detection announced that, on January 13, 20...
AnPac Bio-Medical Science (NASDAQ: ANPC) , a biotechnology company with operations in the United States and China, is reporting its unaudited financial results for the six months ended June 30, 2022. Highlights of the report for the first half of 2022 include total revenue of an estimated $7...
AnPac Bio-Medical Science press release ( NASDAQ: ANPC ): 1H Adj. net loss of $6.6M. Revenue of $0.78M (-44.3% Y/Y). For further details see: AnPac Bio-Medical Science Adj. net loss of $6.6M, revenue of $0.78M
PHILADELPHIA, Dec. 19, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today its unaudited financial result...
AnPac Bio (NASDAQ: ANPC) , a biotechnology company with operations in the United States and China focused on early cancer screening and detection, today announced that it has reached a mutual understanding with nine investors. Through a private placement, the investors will subscribe for and purc...
PHILADELPHIA, Dec. 05, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (Nasdaq: ANPC) (“AnPac Bio” or the “Company”), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, today announced th...
PHILADELPHIA, Dec. 05, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (Nasdaq: ANPC) (“AnPac Bio” or the “Company”), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, today announced th...
AnPac Bio (NASDAQ: ANPC) is a biotechnology company with operations in the United States and China focused on early cancer screening and detection. The company today announced that it has been notified by the Office of the General Counsel of The Nasdaq Stock Market LLC that it has regained compl...
PHILADELPHIA, Nov. 30, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (Nasdaq: ANPC) (“AnPac Bio” or the “Company”), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, today announced th...
News, Short Squeeze, Breakout and More Instantly...
AnPac Bio-Medical Science Co. Ltd. Company Name:
ANPC Stock Symbol:
NASDAQ Market:
Fresh2 Group (NASDAQ: ANPC) , formerly AnPac Bio-Medical Science Co., a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform focused on th...
Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from 'ANPC' to 'FRES' PR Newswire Ticker symbol change effective at the market open May 22, 2023 NEW YORK , May 19, 2023 /PRNewswire/ -- Fresh2 Group Ltd., formerly AnPac Bio-Medical Science...
Fresh2 Group Limited (NASDAQ: ANPC) , formerly AnPac Bio-Medical Science Co., a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform foc...